These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 12523595)
1. Expression of p33(ING1) in hepatocellular carcinoma: relationships to tumour differentiation and cyclin E kinase activity. Ohgi T; Masaki T; Nakai S; Morishita A; Yukimasa S; Nagai M; Miyauchi Y; Funaki T; Kurokohchi K; Watanabe S; Kuriyama S Scand J Gastroenterol; 2002 Dec; 37(12):1440-8. PubMed ID: 12523595 [TBL] [Abstract][Full Text] [Related]
2. Reduced expression of p33(ING1) and the relationship with p53 expression in human gastric cancer. Oki E; Maehara Y; Tokunaga E; Kakeji Y; Sugimachi K Cancer Lett; 1999 Dec; 147(1-2):157-62. PubMed ID: 10660101 [TBL] [Abstract][Full Text] [Related]
3. Identification of the p33(ING1)-regulated genes that include cyclin B1 and proto-oncogene DEK by using cDNA microarray in a mouse mammary epithelial cell line NMuMG. Takahashi M; Seki N; Ozaki T; Kato M; Kuno T; Nakagawa T; Watanabe K; Miyazaki K; Ohira M; Hayashi S; Hosoda M; Tokita H; Mizuguchi H; Hayakawa T; Todo S; Nakagawara A Cancer Res; 2002 Apr; 62(8):2203-9. PubMed ID: 11956069 [TBL] [Abstract][Full Text] [Related]
4. p33(ING1) enhances UVB-induced apoptosis in melanoma cells. Cheung KJ; Li G Exp Cell Res; 2002 Oct; 279(2):291-8. PubMed ID: 12243754 [TBL] [Abstract][Full Text] [Related]
5. Expression and sequence analyses of p33(ING1) gene in myeloid leukemia. Ito K; Kinjo K; Nakazato T; Ikeda Y; Kizaki M Am J Hematol; 2002 Feb; 69(2):141-3. PubMed ID: 11835353 [TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of tumor suppressor p33(ING1b) and its synergy with p53 gene in hepatocellular carcinoma. Zhu Z; Lin J; Qu JH; Feitelson MA; Ni CR; Li FM; Zhu MH World J Gastroenterol; 2005 Apr; 11(13):1903-9. PubMed ID: 15800978 [TBL] [Abstract][Full Text] [Related]
7. Downregulation of nuclear expression of the p33(ING1b) inhibitor of growth protein in invasive carcinoma of the breast. Nouman GS; Anderson JJ; Crosier S; Shrimankar J; Lunec J; Angus B J Clin Pathol; 2003 Jul; 56(7):507-11. PubMed ID: 12835295 [TBL] [Abstract][Full Text] [Related]
8. [p33(ING1) gene expression and mutation in stomach cancer tissues and precarcinomatous tissues]. Ding HZ; Yang D; Wu FR; Li H; Feng K; Zheng SJ; Ni CR; Yu GZ Zhonghua Yi Xue Za Zhi; 2003 Feb; 83(4):320-3. PubMed ID: 12812652 [TBL] [Abstract][Full Text] [Related]
9. Human inhibitor of growth 1 inhibits hepatoma cell growth and influences p53 stability in a variant-dependent manner. Zhu Z; Luo Z; Li Y; Ni C; Li H; Zhu M Hepatology; 2009 Feb; 49(2):504-12. PubMed ID: 19085961 [TBL] [Abstract][Full Text] [Related]
10. p24/ING1-ALT1 and p47/ING1-ALT2, distinct alternative transcripts of p33/ING1. Saito A; Furukawa T; Fukushige S; Koyama S; Hoshi M; Hayashi Y; Horii A J Hum Genet; 2000; 45(3):177-81. PubMed ID: 10807544 [TBL] [Abstract][Full Text] [Related]
11. Diminished expression of ING1 mRNA and the correlation with p53 expression in breast cancers. Tokunaga E; Maehara Y; Oki E; Kitamura K; Kakeji Y; Ohno S; Sugimachi K Cancer Lett; 2000 Apr; 152(1):15-22. PubMed ID: 10754201 [TBL] [Abstract][Full Text] [Related]
12. The tumor suppressor candidate p33(ING1) mediates repair of UV-damaged DNA. Cheung KJ; Mitchell D; Lin P; Li G Cancer Res; 2001 Jul; 61(13):4974-7. PubMed ID: 11431327 [TBL] [Abstract][Full Text] [Related]
13. ING1a and ING1b different expressed in sporadic hepatocellular carcinoma. Chen X; Du J; Zhu T Pathol Biol (Paris); 2009 May; 57(3):e17-21. PubMed ID: 18450387 [TBL] [Abstract][Full Text] [Related]
14. [Significance of p33(ING1b) and p53 gene expression in hepatocellular carcinoma]. Zhu Z; Zhu M; Ni C Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1332-6. PubMed ID: 12509938 [TBL] [Abstract][Full Text] [Related]
15. Relative levels of alternative transcripts of the ING1 gene and lack of mutations of p33/ING1 in haematological malignancies. Bromidge T; Lynas C Leuk Res; 2002 Jul; 26(7):631-5. PubMed ID: 12008079 [TBL] [Abstract][Full Text] [Related]
16. Genetic alterations of tumor suppressor ING1 in human non-small cell lung cancer. Luo ZG; Tang H; Li B; Zhu Z; Ni CR; Zhu MH Oncol Rep; 2011 Apr; 25(4):1073-81. PubMed ID: 21286670 [TBL] [Abstract][Full Text] [Related]
17. Loss of p16 contributes to p27 sequestration by cyclin D(1)-cyclin-dependent kinase 4 complexes and poor prognosis in hepatocellular carcinoma. Matsuda Y; Ichida T; Genda T; Yamagiwa S; Aoyagi Y; Asakura H Clin Cancer Res; 2003 Aug; 9(9):3389-96. PubMed ID: 12960127 [TBL] [Abstract][Full Text] [Related]
18. Reduced expression of cell cycle regulator p18(INK4C) in human hepatocellular carcinoma. Morishita A; Masaki T; Yoshiji H; Nakai S; Ogi T; Miyauchi Y; Yoshida S; Funaki T; Uchida N; Kita Y; Funakoshi F; Usuki H; Okada S; Izuishi K; Watanabe S; Kurokohchi K; Kuriyama S Hepatology; 2004 Sep; 40(3):677-86. PubMed ID: 15349907 [TBL] [Abstract][Full Text] [Related]
19. ING1 represses transcription by direct DNA binding and through effects on p53. Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900 [TBL] [Abstract][Full Text] [Related]
20. [Effects of two variants of ING1 expression on tumor cell growth regulation]. Liu JY; Wu BQ; Zheng J; You JF; Zhong HH; Wang JL Zhonghua Bing Li Xue Za Zhi; 2003 Feb; 32(1):48-51. PubMed ID: 12760804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]